Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NEW JERSEY--(BUSINESS WIRE)--A clinical study to evaluate the prophylactic effect of non-invasive vagal nerve stimulation for the prevention of chronic migraine completed enrollment last week. The study, which is being sponsored by electroceutical healthcare company electroCore, involves 60 patients across six US sites1.
Help employers find you! Check out all the jobs and post your resume.
